Curaleaf Holdings Inc
TSX:CURA

Watchlist Manager
Curaleaf Holdings Inc Logo
Curaleaf Holdings Inc
TSX:CURA
Watchlist
Price: 4.14 CAD -6.12% Market Closed
Market Cap: 3.2B CAD

Curaleaf Holdings Inc
Change in Working Capital

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Curaleaf Holdings Inc
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Curaleaf Holdings Inc
TSX:CURA
Change in Working Capital
$92.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Change in Working Capital
-$15.5B
CAGR 3-Years
-53%
CAGR 5-Years
-50%
CAGR 10-Years
-81%
Bristol-Myers Squibb Co
NYSE:BMY
Change in Working Capital
$2.5B
CAGR 3-Years
N/A
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Change in Working Capital
-$4B
CAGR 3-Years
11%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Change in Working Capital
-$6.5B
CAGR 3-Years
-38%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Eli Lilly and Co
NYSE:LLY
Change in Working Capital
-$6.6B
CAGR 3-Years
N/A
CAGR 5-Years
-112%
CAGR 10-Years
-46%
No Stocks Found

Curaleaf Holdings Inc
Glance View

Curaleaf Holdings Inc., a prominent player in the burgeoning cannabis market, has carved out a significant niche for itself by fully integrating its operations from cultivation to distribution. Founded in 2010, the Massachusetts-based company has rapidly grown to become one of the largest cannabis retailers in the United States. With a keen eye on the complex regulatory landscape, Curaleaf has strategically expanded its footprint across multiple states, adapting to various state laws and regulations. Their operational strategy hinges on vertical integration, meaning they control every stage of the cannabis supply chain. This allows Curaleaf not only to maintain high product quality and consistency but also to maximize margins by reducing costs and gaining efficiencies at all levels of production and retailing. Generating revenue through a combination of wholesale and retail sales, Curaleaf has established a range of products including cannabis flower, oils, edibles, and topical treatments, catering to both medical and recreational customers. The company's retail outlets, spanning across multiple states, are crucial in driving sales, where knowledgeable staff guide customers through intricate product offerings aimed at satisfying diverse consumer needs. Meanwhile, Curaleaf’s wholesale division supplies products to other retail outlets, expanding its market reach and solidifying its brand presence. The synergy between its retail prowess and wholesale operations has allowed Curaleaf to sustain steady revenue growth, positioning it well in a highly competitive and rapidly evolving industry.

CURA Intrinsic Value
2.81 CAD
Overvaluation 32%
Intrinsic Value
Price

See Also

What is Curaleaf Holdings Inc's Change in Working Capital?
Change in Working Capital
92.8m USD

Based on the financial report for Sep 30, 2025, Curaleaf Holdings Inc's Change in Working Capital amounts to 92.8m USD.

What is Curaleaf Holdings Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 1Y
31%

Over the last year, the Change in Working Capital growth was 31%.

Back to Top